Get the Stockscreener App
0.6706
9.74%
-0.0724
Kairos Pharma, Ltd. Stock (KAPA) Forecast
The Kairos Pharma, Ltd. (KAPA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.743, representing a +159.92% increase from the current price of $0.6706. The highest analyst price target is $2.8662, and the lowest is $0.6199.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KAPA Price Target
Average 1.4374
(+114.35% Upside)
Is Kairos Pharma, Ltd. (KAPA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 18.83 | Buy |
| STOCH(9,6) | 4.4007 | Buy |
| STOCHRSI(14) | 7.3036 | Buy |
| MACD(12,26) | -0.2961 | Sell |
| ADX(14) | 17.18 | Neutral |
| William %R | -99.05 | Buy |
| CCI(14) | -99.73 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9974
Sell
|
0.9748
Sell
|
| MA20 |
1.3517
Sell
|
1.2263
Sell
|
| MA50 |
1.7336
Sell
|
1.6548
Sell
|
| MA100 |
2.2252
Sell
|
2.2397
Sell
|
| MA200 |
3.3287
Sell
|
3.4004
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, KAPA could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on KAPA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 18.83 indicates that KAPA is oversold. This indicates that KAPA price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 4.4007 indicates that KAPA is oversold. This indicates that KAPA price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.3036 indicates that KAPA is oversold. This suggests that KAPA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 17.18 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -99.73 indicates that KAPA is still oversold but not to an extreme extent.
Long-term KAPA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kairos Pharma, Ltd. financial reports and earnings history, Kairos Pharma, Ltd. (KAPA) stock could reach $5.0338 by 2030, $75.85 by 2040 and $105.77 by 2050. See the projected annual prices until 2050 of the Kairos Pharma, Ltd. stock below:
- Kairos Pharma, Ltd. (KAPA) is expected to reach an average price of $9.0226 in 2035, with a high prediction of $10.72 and a low estimate of $9.0646. This indicates an $1,245% rise from the last recorded price of $0.6706.
- Kairos Pharma, Ltd. (KAPA) stock is projected to chart a bullish course in 2040, with an average price target of $76.65, representing an $11,330% surge from its current level. The forecast ranges from a conservative $7.1983 to a sky-high $75.85.
- Our analysts predict Kairos Pharma, Ltd. (KAPA) to jump 13,782% by 2045, soaring from $93.14 to an average price of $93.10, potentially reaching $95.79. While $93.14 is the low estimate, the potential upside is significant.
- Kairos Pharma, Ltd. (KAPA) stock is expected to climb by 2050, reaching an average of $97.81, a $14,485% jump from its current level. However, a wide range of estimates exists, with high and low targets of $105.77 and $98.37, respectively, highlighting the market's uncertainty.
Kairos Pharma, Ltd. Stock (KAPA) Year by Year Forecast
Kairos Pharma, Ltd. Stock (KAPA) Price Forecast for 2026
The predicted value for Kairos Pharma, Ltd. (KAPA) in 2026 is set at an average of $3.8367. Estimates vary from a peak of $7.28 to a trough of $0.3934, indicating an +472.13% surge from the present price of $0.6706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.4918 | $0.6199 | $2.8662 | +122.45% |
| December, 2026 | $0.1749 | $0.6457 | $1.3836 | -73.92% |
Kairos Pharma, Ltd. Stock (KAPA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kairos Pharma, Ltd. (KAPA) is $0.9955, with a high forecast of $1.9822 and a low forecast of $0.00871. This indicates an +48.44% increase from the last price of $0.6706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6474 | $0.5392 | $0.6966 | -3.47% |
| February, 2027 | $0.9123 | $0.2578 | $1.9822 | +36.04% |
| March, 2027 | $0.8002 | $0.1629 | $1.2059 | +19.33% |
| April, 2027 | $0.0827 | $0.251 | $0.6652 | -87.67% |
| May, 2027 | $0.5113 | $0.0217 | $0.624 | -23.75% |
| June, 2027 | $0.5576 | $0.2902 | $1.302 | -16.85% |
| July, 2027 | $0.125 | $0.00871 | $0.8632 | -81.36% |
| August, 2027 | $0.145 | $0.0743 | $0.5286 | -78.38% |
| September, 2027 | $0.1045 | $0.1062 | $0.5318 | -84.42% |
| October, 2027 | $0.0289 | $0.0908 | $0.9028 | -95.69% |
| November, 2027 | $0.5985 | $0.0829 | $0.6985 | -10.75% |
| December, 2027 | $0.0435 | $0.0332 | $1.3441 | -93.52% |
Kairos Pharma, Ltd. Stock (KAPA) Price Forecast for 2028
In 2028, Kairos Pharma, Ltd. (KAPA) is projected to reach an average price of $3.877, with a high projection of $6.4167 and a low estimate of $1.3373. This indicates an +478.14% rise from the last price of $0.6706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.1239 | $5.1939 | $5.5587 | +664.08% |
| February, 2028 | $6.6232 | $5.3465 | $5.933 | +887.66% |
| March, 2028 | $6.5742 | $6.4482 | $6.4167 | +880.34% |
| April, 2028 | $5.6942 | $5.8993 | $5.823 | +749.12% |
| May, 2028 | $5.4757 | $4.8457 | $4.9514 | +716.53% |
| June, 2028 | $4.5565 | $4.9688 | $4.9632 | +579.46% |
| July, 2028 | $3.8795 | $4.1315 | $4.2169 | +478.51% |
| August, 2028 | $3.1773 | $3.087 | $3.4035 | +373.80% |
| September, 2028 | $2.5024 | $2.8749 | $2.7349 | +273.16% |
| October, 2028 | $2.8488 | $2.4925 | $2.4003 | +324.81% |
| November, 2028 | $2.3139 | $2.2376 | $2.2888 | +245.05% |
| December, 2028 | $1.282 | $1.3373 | $1.7672 | +91.18% |
Kairos Pharma, Ltd. Stock (KAPA) Price Forecast for 2029
The 2029 price forecast for Kairos Pharma, Ltd. Stock (KAPA) is $6.4768 on average, with a high prediction of $12.59 and a low estimate of $0.3656. This represents an +865.83% increase from the previous price of $0.6706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8924 | $1.0298 | $1.3646 | +33.08% |
| February, 2029 | $0.2756 | $0.3656 | $0.5567 | -58.91% |
| March, 2029 | $12.59 | $0.7718 | $12.59 | +1,778% |
| April, 2029 | $11.34 | $11.76 | $11.45 | +1,592% |
| May, 2029 | $12.20 | $13.13 | $12.53 | +1,719% |
| June, 2029 | $11.85 | $12.05 | $11.29 | +1,668% |
| July, 2029 | $9.9475 | $10.03 | $11.32 | +1,383% |
| August, 2029 | $10.17 | $10.27 | $9.8417 | +1,417% |
| September, 2029 | $8.641 | $9.0131 | $8.7587 | +1,189% |
| October, 2029 | $7.0284 | $7.3896 | $8.1261 | +948.08% |
| November, 2029 | $6.1673 | $6.2373 | $6.3661 | +819.67% |
| December, 2029 | $5.4794 | $5.5494 | $5.8715 | +717.09% |
Kairos Pharma, Ltd. Stock (KAPA) Price Forecast for 2030
Kairos Pharma, Ltd. Stock (KAPA) is expected to reach an average price of $10.45 in 2030, with a high forecast of $19.62 and a low forecast of $1.2833. This signifies an +1,458% surge from the last price of $0.6706.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $4.7464 | $4.8171 | $5.0338 | +607.78% |
| February, 2030 | $3.972 | $4.1897 | $4.1615 | +492.31% |
| March, 2030 | $3.2327 | $3.1719 | $2.9954 | +382.06% |
| April, 2030 | $1.6445 | $1.6695 | $2.8375 | +145.23% |
| May, 2030 | $1.4716 | $1.2833 | $1.3033 | +119.44% |
| June, 2030 | $18.78 | $18.78 | $19.62 | +2,700% |
| July, 2030 | $19.05 | $18.18 | $18.36 | +2,741% |
| August, 2030 | $18.19 | $18.19 | $18.64 | +2,612% |
| September, 2030 | $15.03 | $16.15 | $16.83 | +2,141% |
| October, 2030 | $15.26 | $15.12 | $14.73 | +2,175% |
| November, 2030 | $13.52 | $13.93 | $14.46 | +1,916% |
| December, 2030 | $11.83 | $12.08 | $12.90 | +1,664% |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):